The DEA’s medical marijuana registration portal opened on April 29. By the morning of May 2, nearly 400 businesses had…
An investigation into the infrastructure, incentives, and revenue streams behind prohibition advocacy — using professional writer Alex Berenson’s career as…
Cannabis is quietly emerging as a geopolitical tool in 2026, reshaping global trade, diplomacy and soft power amid energy crises…
By Rob Pero, Founder of Indigenous Cannabis Industry Association The most exciting future for cannabis in the U.S. isn’t coming…
The Trump administration’s rescheduling order moved FDA-approved marijuana drug products and certain state-regulated medical marijuana products from Schedule I to…
By Hirsh Jain via Cannabis Confidential newsletter. Subscribe here. How Zorn’s trajectory from litigator to policymaker echoes Thurgood Marshall. As…
This article originally appeared on IgniteIt and is republished here with permission. The Trump administration’s rescheduling order contains a little-noticed…
The Acting Attorney General is getting the ball rolling on the rescheduling of cannabis from Schedule 1 to Schedule 3,…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov poll found that 59% of…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products regulated under qualifying state medical…